ILAHealth CareCompany Update21 August 2026· 3 min read
Island Pharmaceuticals (ASX: ILA) Boosts Galidesivir Supply as Ebola Surges
Island Pharmaceuticals has ordered a second GMP-grade Galidesivir manufacturing campaign. Total inventory is expected to reach about 700–800 treatment courses in late 2026.